158 related articles for article (PubMed ID: 25998247)
1. Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells.
Morita M; Sekine A; Urano Y; Nishimura T; Takabe W; Arai H; Hamakubo T; Kodama T; Noguchi N
J Biochem; 2015 Oct; 158(4):331-8. PubMed ID: 25998247
[TBL] [Abstract][Full Text] [Related]
2. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.
Yeh M; Cole AL; Choi J; Liu Y; Tulchinsky D; Qiao JH; Fishbein MC; Dooley AN; Hovnanian T; Mouilleseaux K; Vora DK; Yang WP; Gargalovic P; Kirchgessner T; Shyy JY; Berliner JA
Circ Res; 2004 Oct; 95(8):780-8. PubMed ID: 15388640
[TBL] [Abstract][Full Text] [Related]
3. Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A.
Kivelä AM; Dijkstra MH; Heinonen SE; Gurzeler E; Jauhiainen S; Levonen AL; Ylä-Herttuala S
Atherosclerosis; 2012 Dec; 225(2):335-40. PubMed ID: 23102786
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.
Millanvoye-Van Brussel E; Topal G; Brunet A; Do Pham T; Deckert V; Rendu F; David-Dufilho M
Biochem J; 2004 Jun; 380(Pt 2):533-9. PubMed ID: 14992685
[TBL] [Abstract][Full Text] [Related]
5. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
[TBL] [Abstract][Full Text] [Related]
6. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.
Jougasaki M; Kugiyama K; Saito Y; Nakao K; Imura H; Yasue H
Circ Res; 1992 Sep; 71(3):614-9. PubMed ID: 1499109
[TBL] [Abstract][Full Text] [Related]
7. Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL.
Benítez S; Camacho M; Arcelus R; Vila L; Bancells C; Ordóñez-Llanos J; Sánchez-Quesada JL
Atherosclerosis; 2004 Dec; 177(2):299-305. PubMed ID: 15530903
[TBL] [Abstract][Full Text] [Related]
8. Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine.
Domeij H; Hua X; Su J; Bäcklund A; Yan Z; Frostegård AG; Haeggström JZ; Modéer T; Frostegård J
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():72-8. PubMed ID: 23391726
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
Fujita Y; Yoshizumi M; Izawa Y; Ali N; Ohnishi H; Kanematsu Y; Ishizawa K; Tsuchiya K; Tamaki T
Endocrinology; 2006 Mar; 147(3):1377-85. PubMed ID: 16322069
[TBL] [Abstract][Full Text] [Related]
10. Synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of apoptosis on HUVECs by lysophosphatidylcholine.
Tsutsumi H; Kumagai T; Naitoo S; Ebina K; Yokota K
Biol Pharm Bull; 2006 May; 29(5):907-10. PubMed ID: 16651717
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.
Sato N; Kokame K; Miyata T; Kato H
Thromb Haemost; 1998 Jan; 79(1):217-21. PubMed ID: 9459350
[TBL] [Abstract][Full Text] [Related]
12. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine-induced cytotoxicity and protection by heparin in mouse brain bEND.3 endothelial cells.
Tsai TY; Leong IL; Cheng KS; Shiao LR; Su TH; Wong KL; Chan P; Leung YM
Fundam Clin Pharmacol; 2019 Feb; 33(1):52-62. PubMed ID: 29974515
[TBL] [Abstract][Full Text] [Related]
14. Effects of chlorogenic acid on intracellular calcium regulation in lysophosphatidylcholine-treated endothelial cells.
Jung HJ; Im SS; Song DK; Bae JH
BMB Rep; 2017 Jun; 50(6):323-328. PubMed ID: 28088946
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
[TBL] [Abstract][Full Text] [Related]
16. TSG attenuates LPC-induced endothelial cells inflammatory damage through notch signaling inhibition.
Zhao J; Liang Y; Song F; Xu S; Nian L; Zhou X; Wang S
IUBMB Life; 2016 Jan; 68(1):37-50. PubMed ID: 26662286
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
18. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
[TBL] [Abstract][Full Text] [Related]
19. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.
Aoyama T; Fujiwara H; Masaki T; Sawamura T
J Mol Cell Cardiol; 1999 Dec; 31(12):2101-14. PubMed ID: 10640439
[TBL] [Abstract][Full Text] [Related]
20. Activation of liver X receptor attenuates lysophosphatidylcholine-induced IL-8 expression in endothelial cells via the NF-κB pathway and SUMOylation.
Bi X; Song J; Gao J; Zhao J; Wang M; Scipione CA; Koschinsky ML; Wang ZV; Xu S; Fu G
J Cell Mol Med; 2016 Dec; 20(12):2249-2258. PubMed ID: 27489081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
